Introduction
In the conventional ICDs, the arrhythmia detection algorithm relies primarily on a analysis of the ventricular rate and stability, and do not adequately differentiate ventricular tachycardia (VT) from supraventricular tachycardia (SVT). Not unexpectedly, the latter arrhythmias may be misclassi~ed and lead to inappropriate ICD therapy in 20-30% of the implanted patients [1, 2] . This inappropriate therapy frequently manifests as ICD cluster shocks that are not only painful but may also be, at times, proarrhythmic. The speci~city of the arrhythmia detection may be improved by detection enhancements such as sudden onset, stability, electrogram width or sustained rate duration [3, 4] . Their use, however, has not gained widespread acceptance due to con_icting~ndings regarding their potential ef~cacy and potential concerns regarding underdetection of the clinical VT [5] .
The dual chamber ICDs provide a capability for combined detection and analysis of the atrial and ventricular electrograms [6, 7] . This makes it possible to design innovative detection algorithms, which may allow for better differentiation of VT from SVT/atrial brillation (AF). This chapter will provide a critical appraisal of the clinical utility of arrhythmia detection algorithms in the available dual chamber ICDs.
Essentials of the Dual Chamber Detection Algorithms
Dual chamber detection algorithms classify arrhythmias by performing a stepwise analysis of the atrial and ventricular events in regard to their rate, regularity and patterns of the AV relationship. An improvement in the diagnostic speci~city will be expected but should not be at the expense of a decreased detection sensitivity. The occurrence of concomitant atrial and ventricular tachyarrhythmias (dual arrhythmias) is common and the detection algorithm should be accurate enough to recognize and treat VT in such a setting. The algorithm should also be not so complex, or time consuming that its use leads to an inappropriate delay in the detection and therapy of VT/VF. Finally, it should allow for an optimal programming of the atrial sensitivity to avoid over-or under diagnosis of the atrial arrhythmias. The atrial sensing should be sensitive enough to detect~ne atrial~brillation, and speci~c enough to reject far-~eld R waves.
Characteristics of the Dual Chamber Detection Algorithms
Two types of FDA approved dual chamber ICDs are available in USA and include the Ventak AVDR I, II and III (Guidant, St. Paul, MN) and GEM DR (Medtronic Inc, Minneapolis, MN). In both devices, dual chamber detection algorithm is an optional feature and is operative only when SVT discrimination is programmed ON. Two other dual chamber ICDs, not approved for use in USA, include Defender I and II [6] (ELA Medical, Montrouge, France) and Phylax AV (Biotronic, Berlin, Germany). Their detection algorithms fall beyond the scope of this communication and will not be described.
Ventak AVDR
The Ventak AVDR was the~rst dual chamber ICD to be approved in the USA. It has a dual chamber detection algorithm that is designed to differentiate VT from atrial~brillation (AF) and atrial _utter with a rapid and irregular ventricular response. This dual chamber algorithm functions as a detection enhancement and therapy inhibitor and becomes operative when AF Rate Threshold parameter is activated. This parameter is programmable from atrial rate of 200 to 400 BPM but can only be programmed in the VT zone in a two-zone con~guration ICD and in the lowest VT zone in a three-zone con~guration ICD.
Once an episode is fast and long enough to ful~ll VT detection criteria, the 10 most recent atrial and ventricular cycles are analyzed to determine whether the atrial rate is greater than the programmable AF Rate Threshold and whether the ventricular rhythm is stable or unstable. The stability is programmable from 6 to 120 ms. The episode is classi~ed as AF if the AF Rate Threshold criterion is met and the ventricular rhythm is unstable. Therapy continues to be withheld as long as the atrial rate stays above the AF Rate Threshold, the ventricular rhythm remains unstable, and the sustained duration times does not expire.
Two additional safety enhancements need to be emphasized. At any time during an episode classi~ed as AF, if the ventricular rate exceeds the atrial rate by at least 10 BPM, the V Rate Ͻ A rate parameter supersedes other therapy inhibitors and ICD therapy for VT/VF is delivered. This parameter is automatically activated whenever AF Rate Threshold is programmed ON. The second safety enhancement relates to the parameter of Sustained Rate Duration, which makes it possible to put a time limit on how long ICD therapy will continue to be withheld. This parameter is programmable from 10 seconds to 6 minutes in duration.
Clinical data regarding utility of the Ventak AV detection algorithm are limited to a few published abstracts. Kuhlkamp et al. [8] did not report any statistically signi~cant difference in the mean VF detection times between Ventak AV and Ventak MINI (2.40Ϯ0.06 vs 2.0Ϯ0.03 sec, p NS). Jung et al. [9] induced AF at the predischarge EP study in 12 patients implanted with Ventak AV and reported an appropriate inhibition of the ICD therapy in 100% of the induced episodes. In a larger report of 69 patients implanted with Ventak AV [10], the use of AF Rate Threshold led to therapy inhibition in 29 (91%) of the 32 induced episodes of AF and did not interfere with VT therapy delivery in any of the 64 induced episodes of VT.
The Ventak AVDR algorithm is user-friendly, simple in its concept, and places a high emphasis on avoiding an underdiagnosis of VT/VF. It also eliminates the problem of far-~eld R wave oversensing by introducing a cross chamber blanking interval of 86 ms in the atrial lead after a sensed ventricular event. However, atrial brillation with a moderately rapid heart rate is the only supraventricular arrhythmia recognized by this algorithm and it does not differentiate VT from sinus tachycardia or atrial tachycardias with rates Ͻ200 BPM. Also, the algorithm is ill-suited for differentiation of atrial _utter with 2:1 AV block where ICD therapy may be delivered for mistaken diagnosis of VT. Moreover, AF Rate Threshold is programmable only in the lowest VT zone and may, therefore, be of little value in patients with AF and rapid ventricular rates approaching 180 to 200 BPM. Finally, crossblanking period in the atrial lead introduces a potential for under-sensing of the atrial signals, and may thus lead to underdetection of atrial arrhythmias.
GEM-DR detection Algorithm
The GEM-DR has a sophisticated and complex dual chamber detection algorithm that is designed to differentiate a wide spectrum of atrial arrhythmias from VT/VF. These arrhythmias include atrial~brillation, atrial _utter, sinus tachycardia and other SVTs with 1:1 AV conduction. The dual chamber algorithm becomes operative whenever the SVT discriminant criteria are activated. The SVT criteria may be programmed ON individually for AF and _utter, sinus tachycardia, and other 1:1 SVTs or for all types of the SVTs. The SVT limit refers to the minimum ventricular cycle length where SVT discrimination begins and is programmable from 240 to 600 ms (100 to 250 BPM). Unlike the Ventak AVDR, the SVT limit may be programmed ON in any of the ICD zones.
The detection algorithm detects and analyzes atrial and ventricular events to determine the rate (A and V), regularity of the ventricular events, AV dissociation, and AV relationship patterns (Pattern and Rate Logic ™ ). The median atrial and ventricular rates are calculated based on the last 12 events, and the regularity index based on the last 18 V-V intervals. The AV relationship patterns are recognized by the position of atrial relative to the ventricular events and the patterns are determined for several sequential beats (Figure 1) . AV pattern codes have been assigned to different types of arrhythmias and the detection algorithm recognizes various SVTs by the nature of the examined AV patterns. The detection of far-~eld R wave signals is excluded by predetermined criteria and there is no crossblanking in the atrial lead.
A unique feature in the GEM-DR algorithm relates to its hierarchy of tatchyarrhythmia detection. Whenever the SVT criteria are enabled, there is automatic activation of the criteria for double tachycardias. If an episode ful~lls VT/VF detection criteria and the ventricular rate falls within SVT discrimination zone, the ICD will~rst analyze whether a double tachyarrhythmia is present using the criteria listed in Table 1 . If double tachycardia is diagnosed, the ICD treats it as VT of VF with appropriate therapy for the detected zone. If double tachycardia is ruled out, the episode is classi~ed as SVT and further steps in the hierarchy include establishing the speci~c type of SVT (i.e., AF/Flutter, sinus tach or other 1:1 SVTs) ( Table 1) . As long as the episode remains classi~ed as SVT, the evaluation for double tachycardia continues on a beatby-beat basis to guard against the possibility of VT development concomitantly with an underlying SVT.
Limited data exist regarding the clinical utility of the GEM DR detection algorithm [11, 12] . In a multicenter worldwide study of 300 patients implanted with GEM DR [11], the dual chamber detection algorithm appropriately classi~ed 212 (71%) of the 295 true SVT episodes as SVT and 795 (99.7%) of the 797 true VT/VF episodes as VT/VF. Thus, it had a high sensitivity and moderately high speci~city for arrhythmia classi~cation.
The GEM DR dual chamber detection algorithm has the potential capability of differentiating VT/VF from a wide spectrum of atrial arrhythmias over a wide rate range of heart rates (100 to 250 BPM). The detection algorithm, though somewhat complex and cumbersome in its concept, is relatively easy to use and requires only few programming steps for implementation. Unlike in Ventak AVDR, there is no crossblanking period
